Guangya Xiang

4.2k total citations
98 papers, 3.6k citations indexed

About

Guangya Xiang is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Guangya Xiang has authored 98 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 27 papers in Oncology and 27 papers in Biomedical Engineering. Recurrent topics in Guangya Xiang's work include Nanoparticle-Based Drug Delivery (24 papers), RNA Interference and Gene Delivery (22 papers) and Nanoplatforms for cancer theranostics (22 papers). Guangya Xiang is often cited by papers focused on Nanoparticle-Based Drug Delivery (24 papers), RNA Interference and Gene Delivery (22 papers) and Nanoplatforms for cancer theranostics (22 papers). Guangya Xiang collaborates with scholars based in China, United States and Australia. Guangya Xiang's co-authors include Yao Lu, Pengxuan Zhao, Xiang Ma, Robert J. Lee, Chuanchuan He, Tan Yang, Yan Chen, Xiaojuan Zhang, Yongkang Gai and Wenqing Li and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Biomaterials.

In The Last Decade

Guangya Xiang

98 papers receiving 3.5k citations

Peers

Guangya Xiang
Yan Chen China
Rutian Li China
Samaresh Sau United States
Marianne Ashford United Kingdom
Yan Chen China
Guangya Xiang
Citations per year, relative to Guangya Xiang Guangya Xiang (= 1×) peers Yan Chen

Countries citing papers authored by Guangya Xiang

Since Specialization
Citations

This map shows the geographic impact of Guangya Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangya Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangya Xiang more than expected).

Fields of papers citing papers by Guangya Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangya Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangya Xiang. The network helps show where Guangya Xiang may publish in the future.

Co-authorship network of co-authors of Guangya Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Guangya Xiang. A scholar is included among the top collaborators of Guangya Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangya Xiang. Guangya Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Yuying, Xuelian He, Ting Fan, et al.. (2024). Discovery of potent hypoxia-inducible factor-1α (HIF-1α) degraders by proteolysis targeting chimera (PROTAC). Bioorganic Chemistry. 153. 107943–107943. 5 indexed citations
3.
He, Xuelian, Meijing Li, Yuying Li, et al.. (2024). Copper peroxide and cisplatin co-loaded silica nanoparticles-based trinity strategy for cooperative cuproptosis/chemo/chemodynamic cancer therapy. Chemical Engineering Journal. 481. 148522–148522. 29 indexed citations
4.
Ma, Junhui, Lei Fang, Meijing Li, et al.. (2024). Folate‐PEG‐PROTAC Micelles for Enhancing Tumor‐Specific Targeting Proteolysis In Vivo. Advanced Healthcare Materials. 13(20). e2400109–e2400109. 15 indexed citations
5.
Zhao, Pengxuan, Youbin Deng, Guangya Xiang, & Yani Liu. (2021). Nanoparticle-Assisted Sonosensitizers and Their Biomedical Applications. International Journal of Nanomedicine. Volume 16. 4615–4630. 52 indexed citations
6.
Khan, Muhammad Waseem, Pengxuan Zhao, Khan Asifullah, et al.. (2019). <p>Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity</p>. International Journal of Nanomedicine. Volume 14. 3753–3771. 62 indexed citations
7.
Lu, Yao, Yannan Yang, Zhengying Gu, et al.. (2018). Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy. Biomaterials. 175. 82–92. 153 indexed citations
8.
Zhao, Pengxuan, Minsi Li, Yao Wang, et al.. (2018). Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles. Acta Biomaterialia. 72. 248–255. 74 indexed citations
9.
Chen, Yan, Yao Cheng, Pengxuan Zhao, et al.. (2018). Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance. International Journal of Pharmaceutics. 542(1-2). 266–279. 53 indexed citations
10.
Cheng, Yao, Pengxuan Zhao, Tan Yang, et al.. (2018). Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. International Journal of Pharmaceutics. 545(1-2). 261–273. 133 indexed citations
11.
Zhao, Pengxuan, Yao Cheng, Jia You, et al.. (2017). MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma. Nanomedicine Nanotechnology Biology and Medicine. 13(8). 2507–2516. 52 indexed citations
12.
Ludwig, Johannes, Yongkang Gai, Lingyi Sun, et al.. (2016). SW43‐DOX ± loading onto drug‐eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment – An in vitro evaluation. Molecular Oncology. 10(7). 1133–1145. 7 indexed citations
13.
Xiang, Guangya, Taotao Zhou, Fangqi Peng, et al.. (2015). Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes. International Journal of Nanomedicine. 10. 4825–4825. 36 indexed citations
14.
Ye, Peng, Wendian Zhang, Yang Tan, et al.. (2014). Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting. International Journal of Nanomedicine. 9. 2167–2167. 44 indexed citations
15.
Yang, Tan, Bin Li, Shibo Qi, et al.. (2014). Co-delivery of Doxorubicin and Bmi1 siRNA by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in vitro and in vivo. Theranostics. 4(11). 1096–1111. 83 indexed citations
17.
Lu, Yao, Nan Ding, Chang Yang, et al.. (2012). Preparation andin vitroevaluation of a folate-linked liposomal curcumin formulation. Journal of Liposome Research. 22(2). 110–119. 30 indexed citations
18.
Shang, Xianmei, Nan Ding, & Guangya Xiang. (2011). Novel di-n-butyltin(IV) derivatives: Synthesis, high levels of cytotoxicity in tumor cells and the induction of apoptosis in KB cancer cells. European Journal of Medicinal Chemistry. 48. 305–312. 28 indexed citations
19.
Xiang, Guangya. (2007). Specific binding of folate conjugated PGA to FR-positive tumor cells. Zhongguo yaolixue tongbao. 1 indexed citations
20.
Xiang, Hua, et al.. (2004). Total enzymatic synthesis of cholecystokinin CCK-5. Amino Acids. 27(1). 101–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026